Overview

MediSpend is a purpose-built, cloud-based software suite designed for life sciences companies to manage complex global regulatory compliance. Its unified platform provides end-to-end solutions for spend transparency, healthcare professional engagement, grants management, and clinical transparency. Trusted by hundreds of pharmaceutical, biotech, and medical device companies, MediSpend helps organizations reduce risk, maintain audit readiness, and optimize their commercial operations across global markets.

Founder story

Founded in 1999, MediSpend has evolved into a global leader in life sciences compliance. Headquartered in Portsmouth, New Hampshire, the company focuses on bridging the compliance gap for pharmaceutical and medical device companies. Through both organic development and strategic acquisitions, such as Real Life Sciences, MediSpend continues to expand its technology footprint in Governance, Risk, and Compliance (GRC).

What it does

• Automates the collection, validation, and reporting of global transfers of value to healthcare professionals and organizations for transparency compliance
• Facilitates compliant planning, engagement, and payment workflows for HCP/O interactions through embedded rules and strategic monitoring
• Manages internal and external funding requests, grants, and study workflows via a secure, centralized portal with audit-ready documentation
• Provides AI-enabled business intelligence dashboards that offer a 360-degree view of compliance data, risk mitigation, and commercial insights
• Supports clinical transparency by enabling manufacturers to securely submit anonymized data and documents to global health authorities.

Who it's for

• Pharmaceutical Companies
• Biotech Firms
• Medical Device Manufacturers
• Contract Research Organizations

Why it works

• Purpose-built for life sciences, addressing highly specific global regulatory requirements that generic GRC software fails to capture
• Unified, end-to-end suite reduces technology fragmentation, allowing companies to manage multiple compliance functions within one integrated ecosystem
• Embedded rules and proactive monitoring tools help risk-averse organizations ensure defensible, audit-ready global payment programs
• Scalable SaaS infrastructure supports the evolving needs of emerging biotechs through to the world’s largest medical technology enterprises.

Growth strategies

• Strategic acquisition of specialized compliance and anonymization companies like Real Life Sciences and Alucio
• Expansion into AI- enabled medical affairs and stakeholder engagement solutions
• Upselling integrated data and engagement workflows to existing global customer base
• Leveraging deep regulatory expertise to position as a primary compliance partner for CROs

Alternatives

• Veeva Systems
• IQVIA
• MetricStream
• Polaris

Comparison overview

• MediSpend provides a highly specialized, modular SaaS suite tailored strictly for life sciences regulatory compliance, whereas large-scale competitors like Veeva Systems or IQVIA often provide broader, full-spectrum commercial and clinical platforms.